Phase II clinical study of modified FOLFOX7 (intermittent oxaliplatin administration) plus bevacizumab in patients with unresectable metastatic colorectal cancer—CRAFT study

Purpose Continuous treatment with FOLFOX therapy is associated with peripheral nerve toxicity, and to improve this inconvenient side effect various methods of administration are being investigated. A regimen of intermittent oxaliplatin administration by continuous infusion therapy, i.e., modified FO...

Descripción completa

Detalles Bibliográficos
Autores principales: Tezuka, Tohru, Hamada, Chikuma, Ishida, Hideyuki, Ooshiro, Mitsuru, Matsuoka, Hiroshi, Kawasaki, Shingo, Mishima, Hideyuki, Maeda, Kotaro, Sakamoto, Junichi, Koda, Keiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2013
Materias:
Phase II Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771374/
https://www.ncbi.nlm.nih.gov/pubmed/23817973
http://dx.doi.org/10.1007/s10637-013-9982-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771374/
https://www.ncbi.nlm.nih.gov/pubmed/23817973
http://dx.doi.org/10.1007/s10637-013-9982-3

Ejemplares similares